
Dr. Chandragouda Dodagoudar is a senior Medical Oncologist serving as Vice Chairman and Unit Head – Medical Oncology at BLK-Max Super Speciality Hospital, New Delhi. With more than 19 years of experience, he specialises in the medical management of solid tumours and selected blood cancers through advanced systemic cancer treatments.
He completed his MBBS from Mysore University, followed by an MD in General Medicine from Vijayanagara Institute of Medical Sciences, Bellary. He subsequently obtained a DNB in Medical Oncology from Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, and is also a European Certified Medical Oncologist through the European Society for Medical Oncology.
His clinical expertise includes chemotherapy, targeted therapy, immunotherapy and hormonal treatment for different malignancies. His areas of interest include breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynaecological cancers, head and neck cancers and lymphomas.
Dr. Dodagoudar has previously worked at Rajiv Gandhi Cancer Institute and Research Centre, Aakash Healthcare and other recognised medical institutions. He has contributed to clinical research, national and international medical publications and cancer treatment programmes. His professional recognitions include the Best Resident Doctor Award presented by the Vice President of India in 2012.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Chandragouda Dodagoudar for Medical Oncology treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Medical Oncology in India.
Dr. Chandragouda Dodagoudar regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Chandragouda Dodagoudar holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in DNB (Medical Oncology)
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
Targeted therapy, immunotherapy, and chemotherapy tailored to molecular profile for all stages.
Hormone therapy, HER2-targeted agents, chemotherapy, and CDK4/6 inhibitors across all subtypes.
Chemotherapy, targeted biologics (bevacizumab, cetuximab), and immunotherapy for GI malignancies.
Platinum-based chemotherapy, EGFR inhibitors, and PD-L1 checkpoint inhibitors.
R-CHOP, R-DHAP, ABVD, and checkpoint inhibitors for all histological subtypes.
Induction chemotherapy, targeted kinase inhibitors, and novel agent combinations for haematological malignancies.
Platinum/taxane-based regimens, PARP inhibitors (BRCA-mutated), and bevacizumab for ovarian and cervical cancers.
Immunotherapy (checkpoint inhibitors), targeted therapy, and hormonal agents for kidney, bladder, and prostate cancers.
Anthracycline-based first-line chemotherapy and trabectedin for advanced sarcomas.
Evidence-based systemic chemotherapy regimens delivered safely with meticulous toxicity management.
Precision oncology using small molecule inhibitors and monoclonal antibodies matched to tumour biology.
PD-1, PD-L1, and CTLA-4 inhibitors harnessing the immune system to fight cancer.
Comprehensive biomarker profiling to match each patient to the most effective treatment.
Endocrine manipulation and DNA-damage repair inhibitors for hormone-receptor-positive and BRCA-mutated cancers.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.